| Students' perspective on the Dutch National Pharmacotherapy Assessment, a national survey study among final-year medical students | January 2025 | Donker EM, van Rosse F, Janssen BJA, Knol W, Dumont G, van Smeden J, Atiqi R, Hessel M, Richir MC, van Agtmael MA, Kramers C, Tichelaar J; Education committee of the Dutch Society for Clinical Pharmacology and Biopharmacy | 4.3 | Eur J Pharmacol |
| Hospital-wide interventions for reducing or preventing in-hospital prescribing errors: a scoping review | February 2025 | Mahomedradja RF, Wang S, Sigaloff KCE, Tichelaar J, van Agtmael MA. | 3.0 | Expert Opin Drug Saf |
| Understanding factors that influence the drug choice of prescribers: A Q-methodology study | February 2025 | Hartjes MG, Elsevier AEF, Grijpma JWG, Richir MC, van Agtmael MA, Tichelaar J. | 3.1 | Br J Clin Pharmacol |
| The impact of summative, formative or programmatic assessment on the Dutch National Pharmacotherapy assessment: A retrospective multicentre study | February 2025 | Donker EM, van Rosse F, Janssen BJA, Knol W, Dumont G, van Smeden J, Atiqi R, Hessel M, Richir MC, van Agtmael MA, Kramers C, Tichelaar J; Education committee of the Dutch Society for Clinical Pharmacology and Biopharmacy. | 4.3 | Eur J Pharmacol |
| "Doctor, would it surprise you if there were prescribing errors in this patient's medication?" Identifying eligible patients for in-hospital pharmacotherapeutic stewardship: A matched case-control study | March 2025 | Mahomedradja RF, Lissenberg-Witte BI, Sigaloff KCE, Tichelaar J, van Agtmael MA. | 3.1 | Br J Clin Pharmacol |
| Older patients' experiences and needs regarding pharmacotherapeutic care in-hospital and after discharge | March 2025 | Engelen EMC, Knol W, Wuyts SCM, Theunissen DA, Vondeling AM, Cooijmans S, van Herwaarden N, Kramers C, van den Bemt PMLA, van Agtmael MA, Bouvy ML | 2.6 | Patient Educ Couns |
| Renal Outcomes Over the Course of 5 Years of Oral HIV Preexposure Prophylaxis Using Tenofovir Disoproxil/Emtricitabine | March 2025 | Bolluyt DC, van den Elshout MAM, Wijstma ES, Boyd A, Hoornenborg E, De Vries HJC, Prins M, Vogt L, Schim van der Loeff MF, Amsterdam PrEP Project Team in the HIV Transmission Elimination AMsterdam Initiative H-TEAM | 2.9 | Kidney Int Rep |
| Pharmacology and relevant drug interactions of metamizole | May 2025 | Brinkman DJ, Hendriksen LC, Rigter IM, Hollmann MW | 3.1 | Br J Clin Pharmacol |
| Prescribing competence: The pros and cons of different methods for assessment | June 2025 | Brinkman DJ, Donker EM, Tichelaar JT, CP4T programme | 3.1 | Br J Clin Pharmacol |
| Therapeutic reasoning in case reports: Insights into current reporting and learning opportunities | July 2025 | Hartjes MG, Schilder RCH, van Unen RJ, Richir MC, van Agtmael MA, Tichelaar JT | 3.1 | Br J Clin Pharmacol |
| Barriers and solutions for the European prescribing exam: a qualitative world café study | July 2025 | Donker EM, Piët JD, Brinkman DJ, Richir MC, Papaioannidou P, Likic R, Sanz EJ, Christiaens T, Costa JN, De Ponti F, Gatti M, Böttiger Y, Kramers C, van Agtmael MA, Tichelaar J | 2.7 | Eur J Clin Pharmacol |
| A Comprehensive Narrative Review of Protonitazene: Pharmacological Characteristics, Detection Techniques, and Toxicology | August 2025 | Verbeek J, Brinkman DJ | 3.3 | Basic Clin Pharmacol Toxicol |
